Literature DB >> 25363728

Selected ⁶⁸Ga-siderophores versus ⁶⁸Ga-colloid and ⁶⁸Ga-citrate: biodistribution and small animal imaging in mice.

Milos Petrik1, Adela Vlckova, Zbynek Novy, Lubor Urbanek, Hubertus Haas, Clemens Decristoforo.   

Abstract

BACKGROUND: (68)Ga-triacetylfusarinine C (TAFC) and (68)Ga-ferrioxamine E (FOXE) show great potential to be used as highly sensitive and selective tracers for Aspergillus infection imaging. Here we report on a comparison of the ex vivo biodistribution and small animal imaging of (68)Ga-TAFC and (68)Ga-FOXE versus (68)Ga-colloid and (68)Ga-citrate as unspecific control in mice.
METHODS: The radiochemical purity of tested (68)Ga labelled tracers was determined by RP-HPLC or ITLC-SG. Ex vivo biodistribution was studied in normal DBA/2 mice 30 min and 90 min p.i. Static and dynamic imaging were performed using µPET/CT.
RESULTS: (68)Ga-TAFC and (68)Ga-FOXE showed rapid renal excretion and low blood values even 90 min p.i. (68)Ga-TAFC showed almost no retention in other organs while (68)Ga-FOXE displayed some uptake in gastrointestinal tract. (68)Ga-colloid and (68)Ga-citrate revealed significantly different ex vivo biodistribution. (68)Ga-colloid showed pronounced radioactivity retention in the liver, while (68)Ga-citrate displayed high blood values and significant retention of radioactivity in highly perfused organs.
CONCLUSIONS: From the results, both (68)Ga-TAFC and (68)Ga-FOXE have excellent and significantly different in vivo behaviour compared to (68)Ga-colloid and (68)Ga-citrate. (68)Ga-TAFC in particular confirmed its great potential use as a specific tracer for Aspergillus infection imaging.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25363728      PMCID: PMC4843960          DOI: 10.5507/bp.2014.052

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  23 in total

1.  Factors associated with mortality in transplant patients with invasive aspergillosis.

Authors:  John W Baddley; David R Andes; Kieren A Marr; Dimitrios P Kontoyiannis; Barbara D Alexander; Carol A Kauffman; Robert A Oster; Elias J Anaissie; Thomas J Walsh; Mindy G Schuster; John R Wingard; Thomas F Patterson; James I Ito; O Dale Williams; Tom Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

Review 2.  Chemistry and biology of siderophores.

Authors:  Robert C Hider; Xiaole Kong
Journal:  Nat Prod Rep       Date:  2010-05       Impact factor: 13.423

3.  Gallium-68 -- a new opportunity for PET available from a long shelf-life generator - automation and applications.

Authors:  Clemens Decristoforo
Journal:  Curr Radiopharm       Date:  2012-07

Review 4.  68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.

Authors:  Melpomeni Fani; João P André; Helmut R Maecke
Journal:  Contrast Media Mol Imaging       Date:  2008 Mar-Apr       Impact factor: 3.161

Review 5.  Siderophores: structure and function of microbial iron transport compounds.

Authors:  J B Neilands
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

6.  Past, present and future of 68Ge/68Ga generators.

Authors:  F Rösch
Journal:  Appl Radiat Isot       Date:  2012-11-22       Impact factor: 1.513

7.  ALBIRA: a small animal PET∕SPECT∕CT imaging system.

Authors:  F Sánchez; A Orero; A Soriano; C Correcher; P Conde; A González; L Hernández; L Moliner; M J Rodríguez-Alvarez; L F Vidal; J M Benlloch; S E Chapman; W M Leevy
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

Review 8.  Iron and immunity: a double-edged sword.

Authors:  Günter Weiss
Journal:  Eur J Clin Invest       Date:  2002-03       Impact factor: 4.686

Review 9.  Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.

Authors:  Livio Pagano; Murat Akova; George Dimopoulos; Raoul Herbrecht; Lubos Drgona; Nicole Blijlevens
Journal:  J Antimicrob Chemother       Date:  2011-01       Impact factor: 5.790

10.  Uptake of 68gallium in atherosclerotic plaques in LDLR-/-ApoB100/100 mice.

Authors:  Johanna Mu Silvola; Iina Laitinen; Henri J Sipilä; V Jukka O Laine; Pia Leppänen; Seppo Ylä-Herttuala; Juhani Knuuti; Anne Roivainen
Journal:  EJNMMI Res       Date:  2011-08-17       Impact factor: 3.138

View more
  6 in total

Review 1.  Non-invasive radionuclide imaging of trace metal trafficking in health and disease: "PET metallomics".

Authors:  George Firth; Julia E Blower; Joanna J Bartnicka; Aishwarya Mishra; Aidan M Michaels; Alex Rigby; Afnan Darwesh; Fahad Al-Salemee; Philip J Blower
Journal:  RSC Chem Biol       Date:  2022-04-11

2.  Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis.

Authors:  Martin Hoenigl; Thomas Orasch; Klaus Faserl; Juergen Prattes; Juergen Loeffler; Jan Springer; Fabio Gsaller; Frederike Reischies; Wiebke Duettmann; Reinhard B Raggam; Herbert Lindner; Hubertus Haas
Journal:  J Infect       Date:  2018-09-26       Impact factor: 6.072

Review 3.  Imaging fungal infections in children.

Authors:  Alfred O Ankrah; Mike M Sathekge; Rudi A J O Dierckx; Andor W J M Glaudemans
Journal:  Clin Transl Imaging       Date:  2016-01-25

Review 4.  Siderophores for molecular imaging applications.

Authors:  Milos Petrik; Chuangyan Zhai; Hubertus Haas; Clemens Decristoforo
Journal:  Clin Transl Imaging       Date:  2016-10-11

5.  Fully Automated Macro- and Microfluidic Production of [68Ga]Ga-Citrate on mAIO® and iMiDEVTM Modules.

Authors:  Olga Ovdiichuk; Emilie Roeder; Sébastien Billotte; Nicolas Veran; Charlotte Collet
Journal:  Molecules       Date:  2022-02-01       Impact factor: 4.411

6.  Imaging of Pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography.

Authors:  Milos Petrik; Eva Umlaufova; Vladislav Raclavsky; Andrea Palyzova; Vladimir Havlicek; Hubertus Haas; Zbynek Novy; Dalibor Dolezal; Marian Hajduch; Clemens Decristoforo
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.